Incruse Ellipta 55 micrograms inhalation powder, pre-dispensed *

• Company:

  GlaxoSmithKline (Ireland) Ltd

• Status:

  No Recent Update

• Legal Category:

  Product subject to medical prescription which may be renewed (B)

• Active Ingredient(s):

  Umeclidinium bromide

  This medicinal product is subject to additional monitoring.

  *Additional information is available within the SPC or upon request to the company